Sort
30,917 grants matching “tumor microenvironment”
Determination of functional and molecular biomarkers of treatment resistance with multimodal optical spectroscopy
$384,072Narasimhan Rajaram · University Of Arkansas At Fayetteville · R01 · FY2022 · CA
Role of gangliosides in tumor progression
$384,052Stephan Ladisch · Children'S Research Institute · R01 · FY2010 · CA
Role of gangliosides in tumor progression
$384,052Stephan Ladisch · Children'S Research Institute · R01 · FY2009 · CA
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
$384,048Benjamin Allen · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Macrophages induce a tumor-promoting stable EMT in prostate cancer
$384,035Kenneth J. Pienta · University Of Michigan At Ann Arbor · P01 · FY2016 · CA
Steroid hormone regulation of immune responses
$384,018Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2018 · CA
Steroid hormone regulation of immune responses
$384,018Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2021 · CA
Steroid hormone regulation of immune responses
$384,018Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2020 · CA
CSHL CANCER CENTER SUPPORT GRANT
$384,000Bruce W Stillman · Cold Spring Harbor Laboratory · P30 · FY2014 · CA
Targeting the Apoptosis-Resistant Pulmonary Myofibroblast
$383,925James S Hagood · University Of California, San Diego · R01 · FY2012 · HL
Biased chemokine receptor signaling in cancer progression
$383,920Michael B Dwinell · Medical College Of Wisconsin · R01 · FY2022 · CA
Engineering Nanomaterials to Prime Immunity
$383,908James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Multiplexed nanoparticle delivery to increase CRISPR/Cas gene editing for enhanced cancer therapy
$383,887Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2023 · CA
Promotion of tumor invasion and pseudosenescence by the aging microenvironment
$383,875Ashani T Weeraratna · Wistar Institute · R01 · FY2014 · CA
Promotion of tumor invasion and pseudosenescence by the aging microenvironment
$383,875Ashani T Weeraratna · Wistar Institute · R01 · FY2015 · CA
MiR-199~214 cluster at the crossroads of plasticity and malignancy in breastcancer
$383,865Antoine Elias Karnoub · Beth Israel Deaconess Medical Center · R01 · FY2019 · CA
Modulation of Anti-Tumor Immunity by Inhibitory Receptors
$383,814Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2016 · AI
Biased chemokine receptor signaling in cancer progression
$383,766Michael B Dwinell · Medical College Of Wisconsin · R01 · FY2023 · CA
Enzyme-instructed self-assembly for molecular anticancer nanomedicines
$383,751Bing Xu · Brandeis University · R01 · FY2015 · CA
Lymph Node Structure and Function in Tolerance: Role of Laminins
$383,750Jonathan S Bromberg · University Of Maryland Baltimore · R01 · FY2016 · AI
Lymph Node Structure and Function in Tolerance: Role of Laminins
$383,750Jonathan S Bromberg · University Of Maryland Baltimore · R01 · FY2019 · AI
Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy
$383,750Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2020 · CA
Lymph Node Structure and Function in Tolerance: Role of Laminins
$383,750Jonathan S Bromberg · University Of Maryland Baltimore · R01 · FY2015 · AI
Priming pancreatic ductal adenocarcinoma using blood thinners to sensitize the efficacy of checkpoint immunotherapy
$383,750Taslim A Al-Hilal · University Of Texas El Paso · SC1 · FY2023 · GM
Lymph Node Structure and Function in Tolerance: Role of Laminins
$383,750Jonathan S Bromberg · University Of Maryland Baltimore · R01 · FY2017 · AI